PIO continues to demonstrate its safety.
Read More »Diabetes In Control
Issue 154 Item 10 Vigorous Exercise Vs. Walking to Prevent Heart Attacks
While government recommendations say that 30 minutes of moderate daily activity, such as brisk walking, will ward of heart disease, a study found.
Read More »Diabetes? Check Your Mouth for Clues
Warning signs include bleeding gums and bad breath. Consumer surveys show 75 percent of the general population – including 71 percent of baby boomers – don’t know bad breath and bleeding gums are often a strong indicator of diabetes. Dentists are key overall health care partners and can play an …
Read More »Issue 156 Item 5 CGM Aids Glycemic Control in Young Diabetics
A continuous subcutaneous glucose monitoring system improves metabolic control in pediatric patients with type 1 diabetes.
Read More »Issue 151 Item 6 HbA1c Detects Diabetes
HbA1c is a useful marker for case finding of diabetes patients.
Read More »Issue 153 Item 1 New Technique for A Noninvasive Glucose Sensor…The Eyes Have It
Sensor worn as a contact lens which, changes colors according to blood sugars.
Read More »Issue 156 Item 15 Beer Bellys Triple Death Rate for Men with Type 2 Diabetes
The death rate was higher among those who had the metabolic syndrome, despite the absence of cardiovascular disease or diabetes at the beginning of the study.
Read More »Issue 158 Item 7 Water Pills Increase Diabetes Risk in Major Study
Diuretics More Likely To Cause Diabetes Then ACE Inhibitors Or Calcium Channel Blockers.
Read More »Issue 152 Item 11 Direct Cost of Diabetes Has Doubled Since 1997
The annual direct cost of diabetes in the United States more than doubled between 1997 and 2002, Tommy G. Thompson also announced there are over 17 million people with diabetes and another 16 million with PreDiabetes at a press briefing.
Read More »Issue 153 Item 10 Pioglitazone Improves Insulin Sensitivity Compared To Metformi
Pioglitazone exerts a greater benefit on insulin sensitivity in recently diagnosed patients with type 2 diabetes. Pioglitazone and metformin improve glycemic control to a similar extent, but pioglitazone exerts a greater benefit on insulin sensitivity in recently diagnosed patients with type 2 diabetes who have not previously received oral antihyperglycaemics
Read More »
Diabetes In Control. A free weekly diabetes newsletter for Medical Professionals. News and information for Medical Professionals.